3SBIO (01530): In 2024, "Double Eleven", Mandy topped the list of multiple platforms.
Sansei Pharmaceuticals (01530) has announced that its subsidiary, Zhejiang Sansei Mandi Pharmaceutical Co., Ltd. (Sansei Mandi...
3SBIO (01530) announced that its subsidiary Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. (Sansheng Mandi) achieved great success during the "Double 11" event in 2024. The main brand Mandi ranked first in the OTC brand cumulative payment GMV list on Tmall platform. The core product Mandi hair growth foam spray topped the OTC single product GMV payment list on JD Pharmacy. The main brand Mandi was also ranked first in the medical and health brand payment GMV list on Douyin Mall.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
